Nevertheless, the simplicity of the Macroduct and its minimal background contamination make It a useful collection device for the assay of the trace constituents of sweat.
An Optimized Method for Measuring CyclosporinA with 1251-Labeled Cyclospori n RobIn A. Felder,' Theodore E. MIffIIn,"3 and Bahar Bastani2
We evaluated the use of the new iodinated ligand for the in vitro measurement of cyclosporin A by radioimmunoassay (AlA). Substitution of the iodinated cyclosporin (1251-CyA)for the corresponding tritium-labelet.. analog (3H-CyA) considerably simplifies and accelerates the currently available RIA, and improves its precision. Analysis of the respective doseresponse curves showed that the 50% B0 value was lower for the 1251-CyA assay than for the 3H-CyA assay (37 vs 77 zg/L). Use of whole-blood specimens minimized interferences from temperature and hematocrit. We conclude that the use of 1251-CyA in a commercially available RIA for whole-blood specimens is accessible to most laboratories and provides rapid, reproducible data for management of transplant patients.
AddItIonal Keyphrases: radloimmunoassay . 125 and 3H tracers compared variation, source of renal transplant immu-
nosuppressive drugs
Cyclosporin A (CyA), a cyclic undecapeptide of fungal origin, acts as a potent immunosuppressant by inhibiting the activation of T-lymphocytes (1).' The clinical use of CyA is complicated by the narrow therapeutic 'window" between inadequate immunosuppression from too low a dose and nephrotoxicity, hepatotoxicity, and sepsis from too much drug (2, 3). Periodic monitoring of CyA concentrations is thus essential (4).
Measurement of CyA has been complicated by the lack of correlation between administered dose and its concentration in blood. This lack of correlation has been due, in part, to the variation in drug metabolism from patient to patient. Moreover, the lack of consistency in CyA measurement between laboratories has contributed to the confusion over what is an adequate therapeutic concentration of CyA in blood. Finally, the lack of uniformity in specimen collection nd analysis has compounded confusion by reports of CyA measurement in serum, plasma, and whole blood at different temperatures (4,25,37 #{176}C) by two different analytical techniques, RIA (5) and "high-performance" liquid chromatography (HPLC) (6, 7).
We have tried to develop an optimized procedure for measuring CyA in whole blood at room temperature, exploiting the convenience and speed of an RIA with 'Ilabeled CyA (1I-CyA) as the tracer. In addition, we will discuss the effect of iodination on ligand affinity for antibodies to CyA.
Materials and Methods
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Samples: Blood samples were collected into heparinized tubes from renal transplant patients already receiving CyA. Blood samples used for kinetic studies were also collected from these patients and transported at 37-40 #{176}C to the laboratory, where they were than divided into aliquots for further use. For routine analysis, whole-blood samples were allowed to equilibrate at room temperature for 60 mm before processing. The blood sample was well mixed by inversion and a 100-pL aliquot was added to 700 pL of buffer B (Tris, 20 CyA by the 'I-CyA procedure.
Hematocrit study: To investigate the influenceof hematocrit, we prepared a series of samples containing various proportions of erythrocytesas follows.Whole-bloodsamples from each of two transplant patients receiving CyA were centrifuged and the plasma removed. Blood samples obtained from normal, healthy volunteers were used as a source of additional erythrocytes, which we addedto (a) two patients' plasmas containing cyclosporin or (b) normal plasma to which CyA standard solution was added. The resulting hematocrits ranged from 13 to 47%, as measured with a Beckman Microfuge H. After a 90-mn incubation at 37#{176}C, we measured CyA in both plasma (obtainedby centrifugation at 25 #{176}C for 15 mm) and whole bloodby the 'I-CyA procedure.
Quality control: We prepared a series ofcontrols by adding sufficient quantities of purified CyA to heparinized plasma from persons not receiving CyA. Aliquots were stored at -70 #{176}C until needed.
Results
Using identical concentrationsof CyA for calibration, we obtained a similar but not equivalent response with the two tracers (Figure 1) The precision of the CyA assay with both tracers is reported in Table 1 . The CV with the 1I-CyA tracer was half that with 3H-CyA. This improved precision was also observed when the two standard curves were compared (Figure 1 ). Figure 3 illustrates the results for a patient's plasma serially diluted with buffer B. The upper limit of linearity for the CyA assay with the lssICYA tracer was estimated at 400 ng/mL. The lower limit of detection (defined by 85% of the B0 value) was 10 ng/mL for lssICyA, 17 ng/mL for 3H-CyA. transplant patients as measured by both methods. Mahoney and Orf (10), using the same two tracers, measured the concentration of CyA in serum and found a comparable correlation (slope = 1.16, y-intercept = 11.09, r = 0.98,
Using whole blood from the four patients who had receivedrenal transplants, we investigated the effect of temperature on CyA distribution. Concentrations of CyA in plasma were measured at 4, 25, and 37 #{176}C at regular intervals up to 8 h. In this study, samples appeared to achievesteady-state equilibrium within 60 min of changing the temperature to 25#{176}C (data not shown).A large variation was observed within the seriesfor each patient, regardless of incubation temperature.
To study the effect of.dilution on observed values for CyA in whole blood, we usedboth patients' samples and normal whole blood with added CyA. Figure 5 showsthe results of increasing the dilution ratio. When known quantities of pure CyA were added into normal whole-blood samples, analytical recoveries were less than quantitative when thE volumeratio of whole bloodto buffer B was <1:5. Recoveries were constant and exceeded 90% when this dilution rati was 1:7. Similar responseswere observedwith patients samples (data not shown).
When 34 blood samples from renal-transplant patients were assayedfor both whole-bloodand plasma CyA concentrations, ratios of whole blood:plasxna CyA ranged from 1.#{128} to 8.1 (mean = 4.7, SD = 1.5). Slightly lower ratios hays been reported with quench-correctedRIA (11) or RIA ol diethyl ether extractsof whole blood(12). ples from a seriesof patients, the responsevaried from zerc to significantly affected ( Figure 6 ). In two of the thres plasma series(patient "B", and pure CyA "C"), we observed a strong correlation between CyA concentrations and changes in hematocrit. survey conducted by the Central Indiana Regional Blood Center reported using HPLC to quanti1r CyA. In contrast, RIA measures the sum of the parent compound and its metabolites,some of which are possibly active as immunosuppressive agents or toxins. The RIA procedure requires lesstime and capital outlay and is therefore performed by more transplant centers than is HPLC, We designedthis study to present both an optimized specimen-handling protocol and an optimized RIA procedure for CyA measurement, given the need for a consensus in CyA analysis (13) .
Table1. PrecIsionof Theseand
Radioiodinated cyclosporin appears to be a useful ligand when CyA is measured by competitive-binding analysis. The dose-response curve shiftsto the left, however, when '251-CyA is substituted for 3H-CyA, analogous to the shift observed when the heterologous tracer 'I-labeled progesterone was substituted for its tritium analog (14) . Although the 'I-CyA dose curve appears only slightlydifferent from the 3H-CyA curve, there are several important differences. We calculated linearity and detection limits similar to those reported for 3H-CyA (5, 8), but we obtained different regression statistics for our patient comparison study than those described for 1I-CyA (10). Presumably, our use of plasma samples instead of serum (10) is responsiblefor these differences.
Substituting radio-iodinated CyA in the current immuneassay improved both its precision (Table 1) 
Discussion
Due to a lack of consensus, CyA is routinely quantified by both RIA (5) and HPLC (6, 7) . For the measurement of unmetabolized CyA, HPLC appears to be the method of choice; however sample throughput is slow and expensive equipment is required. In addition, several antibiotics (nitrofurantoin,sulfamethoxazole) appear tointerfere in these assays (personal communication, Dr. Terry Phillips, Dept metabolism (21,22) .
Earlierinvestigations have shown CyA is extensively metabolized to at least 10 different species (16); i.e., <1% of intact CyA was recovered in urine after 96 h (23) . As a result, appreciable amounts of CyA metabolites probably accumulate in most patients on long-term CyA dosage regimens (22) . Because the antibody currently used in the RIA method cross reacts to various extents (7-32%) with these compounds (5,8) , metabolite concentrations measured with the RIA (3H-CyA) technique have probably been underestimated (3, 12, 24, 25) . In contrast, a more nearly accurate determination of total CyA species with I-CyA is possiblebecause CyA metabolitesdisplace more of this tracerfrom the antibody than they do 3H-CyA. For a given concentration ofCyA species (CyA plus CyA metabolites), this increased displacementwillresult ina lower%B0 value being measured, which corresponds to a higher CyA concentration. The decreased affinity of the sheep antibody for the iodinated tracer should therefore provide a more nearly accurate measurement of the concentration of total CyA species.
In conclusion we suggest the most precise, rapid, and inexpensive method to measure CyA isa RIA method in which the tritiated traceris replacedby 'I-CyA. The correspondingsample-of-choice appears to be whole blood.
Accuracy of the modified assay can be maintained by periodic comparison of results with those by HPLC orby use of a control with known CyA content.
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